SEP 10, 2026 · OBSERVATIONAL STUDY
The Potential of Mesenchymal Stromal Stem Cells to Correct Immune and Metabolic Dysfunctions in Circulating Immune Cells During Sepsis: An Ex Vivo Pilot Study.
ClinicalTrials.gov
This is a registry record for an unstarted ex vivo pilot study with no results posted; it describes a hypothesis-driven mechanistic study designed to test whether mesenchymal stromal cells can correct immune dysfunction in sepsis blood samples.
Reported
Planned enrollment51
Primary outcome measureConcentration of TNF-α in supernatant from…
Study phaseObservational